AVM Biotechnology Company
AVM Biotechnology is a clinical stage company.
.jpeg)
Technology:
CAR-T therapy
Industry:
Private, Small&Large Molecules
Headquarters:
Seattle, Washington, United States
Founded Date:
2008-01-01
Employees Number:
11-50
Investors Number:
3
Total Funding:
24348000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-06-14
Last Funding Type:
Grant
Register and Claim Ownership